Literature DB >> 31882481

Expression of Podoplanin in Mammary Cancers in Female Dogs.

Paulina Borecka1, Rafal Ciaputa2, Izabela Janus2, Aleksandra Piotrowska3, Katarzyna Ratajczak-Wielgomas3, Alicja Kmiecik3, Marzena Podhorska-Okolów4, Piotr Dzięgiel3,5, Marcin Nowak2.   

Abstract

BACKGROUND/AIM: Mammary neoplasms are very common tumours in female dogs. Cancer-associated fibroblasts (CAFs) play an important role in the oncogenesis process. One of the useful proteins used in the diagnostics of CAFs cells is podoplanin (PDPN). The aim of our study was to assess the expression of PDPN in mammary cancer in female dogs.
MATERIALS AND METHODS: Our study cohort included 61 cancers and 21 adenomas of the mammary tumour in bitches. Expression of podoplanin, Ki-67 and HER2 was determined using the Immunohistochemical (IHC) method. PDPN expression at the mRNA level was determined using real-time PCR.
RESULTS: Expression of PDPN in CAFs was observed in 22.9% of cases of mammary cancers in bitches, with no PDPN expression in adenomas. A positive correlation was found between the expression of PDPN in CAFs and the grade of histological malignancy and expression of Ki-67.
CONCLUSION: PDPN plays a significant role during the process of carcinogenesis of mammary tumours in female dogs. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  CAFs; PDPN; Podoplanin; adenoma; female dog; mammary tumour

Mesh:

Substances:

Year:  2020        PMID: 31882481      PMCID: PMC6984085          DOI: 10.21873/invivo.11763

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  36 in total

Review 1.  An overview of HER2.

Authors:  C Lohrisch; M Piccart
Journal:  Semin Oncol       Date:  2001-12       Impact factor: 4.929

Review 2.  Jekyll and Hyde: the role of the microenvironment on the progression of cancer.

Authors:  Michael Allen; J Louise Jones
Journal:  J Pathol       Date:  2010-10-29       Impact factor: 7.996

Review 3.  Canine mammary tumours, an overview.

Authors:  N Sleeckx; H de Rooster; E J B Veldhuis Kroeze; C Van Ginneken; L Van Brantegem
Journal:  Reprod Domest Anim       Date:  2011-06-06       Impact factor: 2.005

4.  HER2/EGFR-AKT Signaling Switches TGFβ from Inhibiting Cell Proliferation to Promoting Cell Migration in Breast Cancer.

Authors:  Fei Huang; Shiwen Luo; Qiaoni Shi; Yuzhen Li; Linlin Xu; Chi Xu; Fenfang Chen; Hai Wang; Hongwei Liao; Zai Chang; Fang Liu; Xiang H-F Zhang; Xin-Hua Feng; Jing-Dong J Han; Ye-Guang Chen
Journal:  Cancer Res       Date:  2018-08-31       Impact factor: 12.701

5.  Podoplanin-expressing cancer-associated fibroblasts are associated with poor prognosis in invasive breast cancer.

Authors:  Sebastian F Schoppmann; Anna Berghoff; Carina Dinhof; Raimund Jakesz; Michael Gnant; Peter Dubsky; Bettina Jesch; Harald Heinzl; Peter Birner
Journal:  Breast Cancer Res Treat       Date:  2012-02-17       Impact factor: 4.872

6.  Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors.

Authors:  Vivien Schacht; Soheil S Dadras; Louise A Johnson; David G Jackson; Young-Kwon Hong; Michael Detmar
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

Review 7.  Podoplanin - a small glycoprotein with many faces.

Authors:  Maciej Ugorski; Piotr Dziegiel; Jaroslaw Suchanski
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

8.  Evaluation of immunohistochemical markers of lymphatic and blood vessels in canine mammary tumours.

Authors:  N Sleeckx; L Van Brantegem; E Fransen; G Van den Eynden; C Casteleyn; E Veldhuis Kroeze; C Van Ginneken
Journal:  J Comp Pathol       Date:  2012-11-02       Impact factor: 1.311

Review 9.  Canine mammary tumors: a review and consensus of standard guidelines on epithelial and myoepithelial phenotype markers, HER2, and hormone receptor assessment using immunohistochemistry.

Authors:  L Peña; A Gama; M H Goldschmidt; J Abadie; C Benazzi; M Castagnaro; L Díez; F Gärtner; E Hellmén; M Kiupel; Y Millán; M A Miller; F Nguyen; A Poli; G Sarli; V Zappulli; J Martín de las Mulas
Journal:  Vet Pathol       Date:  2013-11-13       Impact factor: 2.221

10.  Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.

Authors:  Antonio C Wolff; M Elizabeth H Hammond; David G Hicks; Mitch Dowsett; Lisa M McShane; Kimberly H Allison; Donald C Allred; John M S Bartlett; Michael Bilous; Patrick Fitzgibbons; Wedad Hanna; Robert B Jenkins; Pamela B Mangu; Soonmyung Paik; Edith A Perez; Michael F Press; Patricia A Spears; Gail H Vance; Giuseppe Viale; Daniel F Hayes
Journal:  J Clin Oncol       Date:  2013-10-07       Impact factor: 44.544

View more
  1 in total

1.  Expression of Periostin in Mammary Cancer Cells of Female Dogs.

Authors:  Paulina Borecka; Rafal Ciaputa; Izabela Janus; Joanna Bubak; Aleksandra Piotrowska; Katarzyna Ratajczak-Wielgomas; Marzenna Podhorska-OkolÓw; Piotr DziĘgiel; Marcin Nowak
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.